Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2400138	帕妥珠曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products	Supplementary Application	2024-06-28	Roche Pharma (Schweiz) AG	view
JYSB2400139	帕妥珠曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products	Supplementary Application	2024-06-28		view
JYSB2400170	帕妥珠曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products	Supplementary Application	2024-08-03		view
JYSB2400171	帕妥珠曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products	Supplementary Application	2024-08-03	Roche Pharma (Schweiz) AG	view